Himension Capital (Singapore) Pte. Ltd. Crispr Therapeutics Ag Transaction History
Himension Capital (Singapore) Pte. Ltd.
- $1.41 Billion
- Q4 2024
A detailed history of Himension Capital (Singapore) Pte. Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Himension Capital (Singapore) Pte. Ltd. holds 80,770 shares of CRSP stock, worth $3.76 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
80,770
Previous 81,145
0.46%
Holding current value
$3.76 Million
Previous $3.81 Million
16.63%
% of portfolio
0.23%
Previous 0.3%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$418 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$407 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$178 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$129 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$128 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.63B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....